{
  "nct_id": "NCT16113819",
  "indication": "Asthma",
  "phase": "Phase 2/3",
  "sample_size": 1178,
  "duration_weeks": 41,
  "dropout_rate": 0.14,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Asthma exacerbation reduction"
  ],
  "secondary_endpoints": [
    "ACQ score improvement"
  ],
  "outcome_summary": "Failed to reach statistical significance on primary endpoint",
  "success": 0,
  "failure_reason": "Unexpected safety signal",
  "start_date": "2023-08-27",
  "completion_date": "2024-06-09"
}